PACDB provides the information on pathogens (e.g. bacteria, fungus, toxin and virus) adhering to carbohydrates expressed on the cell surface of host animals or plants.
Source | Last Updated |
---|---|
Pathogen Adherence to Carbohydrate Database (PACDB) | June 1, 2016 |
Species | Pathogen Adherence Molecule ▼ | Ligand Name | Ligand Feature | Target Source | Glycan Sequence | Binding | PubMed ID |
---|---|---|---|---|---|---|---|
Helicobacter pylori | Unknown | Monohexyl ceramides (MHCer) | Glycolipids | Binding | 16088272 | ||
Poliovirus | Unknown | CD155 | Glycoproteins | Binding | 12663789 | ||
Poliovirus | Unknown | Poliovirus receptors (PVRs) | Glycoproteins | Binding | 12663789 | ||
Helicobacter pylori | Unknown | Mucin | Glycoproteins | Binding | 16088272 | ||
Influenza virus | Unknown | Bovine submaxillary mucin (BSM) | Glycoproteins | Binding | 1740131 | ||
Helicobacter pylori | Unknown | Glycosphingolipids | Glycosphingolipids | Binding | 16088272 | ||
Helicobacter pylori | Unknown | Mono-N-propionylated S-3-PG (paragloboside) | Glycosphingolipids | Binding | 15659615 | ||
Helicobacter pylori | Unknown | Mono-de-N-acetylated S-3-PG (paragloboside) | Glycosphingolipids | Binding | 15659615 | ||
Helicobacter pylori | Unknown | Phosphatidylethanolamine (PE) | Non-glycosylated Lipids | Binding | 16088272 | ||
Helicobacter pylori | Unknown | Phospholipids | Non-glycosylated Lipids | Binding | 16088272 | ||
Norovirus | Unknown | Blood group Lewis b (Leb) antigen | Oligosaccharides | Binding | 18701592 | ||
Helicobacter pylori | Unknown | Blood group antigens | Oligosaccharides | Binding | 16088272 | ||
Helicobacter pylori | Unknown | Blood group Lewis b (Leb) antigen | Oligosaccharides | Binding | 16088272 | ||
Lactobacillus johnsonii | Unknown | Blood group Lewis b (Leb) antigen | Oligosaccharides | Binding | 11087711 | ||
Plasmodium falciparum | Unknown | Polylactosamine of band 3 | Polysaccharides | Binding | 8574698 | ||
Actinomyces viscosus | Unknown | GD1a | Disialoglycosphingolipids | Human brain | NeuAc(a2-3)Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer | Not Binding | 2358461 |
Actinomyces viscosus | Unknown | GD1b | Disialoglycosphingolipids | Human brain | Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-8)NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer | Not Binding | 2358461 |
Mycoplasma pneumoniae | Unknown | GD1a | Disialoglycosphingolipids | Human colon adenocarcinoma cells (WiDr ) | NeuAc(a2-3)Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer | Not Binding | 2470753 |
Mycoplasma pneumoniae | Unknown | GD1b | Disialoglycosphingolipids | Human colon adenocarcinoma cells (WiDr ) | Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-8)NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer | Not Binding | 2470753 |
Lactobacillus casei | Unknown | GD1a | Disialoglycosphingolipids | Intestinal tract | NeuAc(a2-3)Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer | Not Binding | 8912650 |
Lactobacillus casei | Unknown | GD3(NeuAc) | Disialoglycosphingolipids | Intestinal tract | NeuAc(a2-8)NeuAc(a2-3)Gal(b1-4)Glc(b1-1)Cer | Not Binding | 8912650 |
Actinomyces naeslundii | Unknown | GD1a | Disialoglycosphingolipids | Human brain | NeuAc(a2-3)Gal(b1-3)GalNAc(b1-4)[NeuAc(a2-3)]Gal(b1-4)Glc(b1-1)Cer | Not Binding | 2358461 |
Mycoplasma pneumoniae | Unknown | Seminolipid (Sulfogalactosylglycerolipid) | Glycolipids | Human colon adenocarcinoma cells (WiDr ) | Gal(3SO4)(b1-3)-alkylacylglycerol | Binding | 2470753 |
Norovirus | Unknown | Sialyl-dimeric Lewis x (SdiLex-HSA) | Glycoproteins | Human serum albumin | NeuAc(a2-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)[Fuc(a1-3)]GlcNAc(b1-3)Gal(b1-4)Glc(c)-APD | Binding | 19054801 |
Influenza virus | Unknown | Sialyl-6-Paragloboside (S-6-PG; α2,6-sialylparagloboside) | Monosialoglycosphingolipids | Granulocytes | NeuAc(a2-6)Gal(b1-4)GlcNAc(b1-3)Gal(b1-4)Glc(b1-1)Cer | Binding | 8823909 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024